5-134607069-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_016103.4(SAR1B):c.481-3T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,540,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016103.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAR1B | NM_016103.4 | c.481-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000402673.7 | NP_057187.1 | |||
SAR1B | NM_001033503.3 | c.481-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001028675.1 | ||||
SAR1B | XM_047417257.1 | c.481-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_047273213.1 | ||||
SAR1B | XM_047417258.1 | c.277-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_047273214.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAR1B | ENST00000402673.7 | c.481-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_016103.4 | ENSP00000385432 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000917 AC: 23AN: 250954Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135612
GnomAD4 exome AF: 0.000266 AC: 369AN: 1388476Hom.: 0 Cov.: 22 AF XY: 0.000259 AC XY: 180AN XY: 695242
GnomAD4 genome AF: 0.000282 AC: 43AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74384
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2021 | The c.481-3T>C intronic alteration consists of a T to C substitution 3 nucleotides before exon 8 (coding exon 6) of the SAR1B gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change falls in intron 7 of the SAR1B gene. It does not directly change the encoded amino acid sequence of the SAR1B protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs369515030, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with SAR1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1055550). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at